China Medicine Corporation (CHME)

USD 0.0

(0.0%)

EBITDA Summary of China Medicine Corporation

  • China Medicine Corporation's latest annual EBITDA in 2009 was 13.27 Million USD , up 82.84% from previous year.
  • China Medicine Corporation's latest quarterly EBITDA in 2010 Q3 was 2.31 Million USD , down -21.03% from previous quarter.
  • China Medicine Corporation reported an annual EBITDA of 11.34 Million USD in 2008, up 22.65% from previous year.
  • China Medicine Corporation reported an annual EBITDA of 9.19 Million USD in 2007, up 22.81% from previous year.
  • China Medicine Corporation reported a quarterly EBITDA of 719.56 Thousand USD for 2010 Q1, down -92.55% from previous quarter.
  • China Medicine Corporation reported a quarterly EBITDA of 2.93 Million USD for 2010 Q2, up 307.2% from previous quarter.

Annual EBITDA Chart of China Medicine Corporation (2009 - 2004)

Historical Annual EBITDA of China Medicine Corporation (2009 - 2004)

Year EBITDA EBITDA Growth
2009 13.27 Million USD 82.84%
2008 11.34 Million USD 22.65%
2007 9.19 Million USD 22.81%
2006 6.34 Million USD 23107.62%
2005 -32.5 Thousand USD -101.29%
2004 2.53 Million USD 0.0%

Peer EBITDA Comparison of China Medicine Corporation

Name EBITDA EBITDA Difference
DH Enchantment Inc. -145.23 Thousand USD 9243.042%
Exlites Holdings International, Inc. -90.49 Thousand USD 14773.444%
Itonis, Inc. -38.31 Thousand USD 34760.506%
One Step Vending Corp. -26.55 Thousand USD 50109.19%
MediPal Holdings Corporation 431.52 Million USD 96.923%
PD-Rx Pharmaceuticals, Inc. -51.41 Thousand USD 25923.995%
Pharmagen, Inc. -2.89 Million USD 558.895%
Suzuken Co., Ltd. 340.78 Million USD 96.104%